Antibody drug may cut Covid-19 hospitalizations, company says

Antibody drug may cut Covid-19 hospitalizations, company says.

9/16/2020 10:59:00 PM

Antibody drug may cut Covid-19 hospitalizations, company says.

Eli Lilly released partial results from a study on its monoclonal antibody drug.

They are being tested to treat newly diagnosed Covid-19 patients in hope of preventing serious disease or death, and to try to prevent infection in people at high risk of that such as nursing home residents and health workers.Wednesday’s results come from 450 people in a mid-stage study testing an antibody jointly developed by Indianapolis-based Lilly and the Canadian company AbCellera in people with Covid-19 symptoms not severe enough to warrant hospitalization. The drug is given once through an IV and was tested at three doses. Neither the patients nor their doctors knew which patients received the drug or placebo infusions.

Opinion: Breonna Taylor's death reminds me this country doesn't love me as much as I love it 8 Texas cities were alerted to a brain-eating amoeba found in water supply This plumber set up a program to introduce girls to the trades in hopes they will follow in her bootsteps

Download theNBC News appfor full coverage of the coronavirus outbreakHospitalization or ER visits occurred in 1.7 percent, or 5 of 302 patients given the drug and 6 percent or 9 of 150 of those given placebo. The company did not disclose whether those results met scientific tests to rule out that they could have occurred by chance alone.

The company felt that giving the actual numbers"told the story in the most balanced way,” said Lilly’s chief scientific officer, Dr. Daniel Skovronsky.The difference seems large enough to suggest a true benefit and the result is “promising” even though the study missed its main goal, said Dr. Peter Bach, a health policy expert at Memorial Sloan Kettering Cancer Center in New York with no role in the study.

The study will continue to test the antibody drug in combination with another from a Chinese company, Junshi Biosciences.Three late-stage studies of italso are underway, including two sponsored by the U.S. National Institutes of Health.Lilly has already started manufacturing its antibody drug, hoping to have hundreds of thousands of doses ready by fall if studies give positive results.

Another company that developed an antibody drug cocktail against Ebola — Regeneron Pharmaceuticals Inc. — now is testing a two-antibody drug for coronavirus. Read more: NBC News »

Ruth Bader Ginsburg represented what 'is best about America': Bill Clinton

Former President Bill Clinton, who nominated Ruth Bader Ginsburg to the Supreme Court in 1993, appeared on ABC's 'This Week.'

Watch 'Heated Vaccine Debate - Kennedy Jr. vs Dershowitz' on YouTube TRUST THE SCIENCE. LISTEN TO THE EXPERTS. In 2008, Michael Greger, MD, physician,internationally recognized expert on public health issues discussed worst pandemics in history, and how to treat the cause by preventing the emergence of pandemic viruses in the first place.

Incredible. There's various nano antibody efforts and the best really deserve support/coverage Saying is easy doing is hard and can be confirmed in a transparent society

Lilly says antibody drug cuts hospitalization among moderate COVID-19 patientsEli Lilly and Co said on Wednesday interim trial data showed its experimental antibody treatment reduced the need for hospitalization and emergency room visits for patients with moderate COVID-19. Lilly Says. Is this like Jane Says by Jane's Addiction? BREAKING:CCP CREATED THE COVID-19 VIRUS 🦠

Latino nurses push through COVID-19 burnout, sleepless nights and lost loved onesLatino health care workers talk about the impact of COVID-19 on their mental health and the way it has impacted their lives. My anxiety is from the media! Did these nurses never consider that they would be exposed to contagious illnesses? Not sure why you single out Latino nurses. ALL NURSES are in the same boat

Opinion: College football celebrates COVID-19 outbreaks, ridicules cautious approachThe truth about what has gone on at college football programs over the past few months in pursuit of playing this fall does not present a flattering picture, writes usatodaysports' Dan Wolken. usatodaysports Everybody has struggled to deal with covid. Colleges n universities are no different. usatodaysports I'm not surprised at their disgusting stupidity. We got the bLM nfl supporting and wearing the names of Child Molesters, RAPIST, Violent criminals,Gang Bangers,Felons. usatodaysports Remember hiding concussions do not create long term problems they do. Sports before education?

No sign of second wave before election, but U.S. COVID-19 cases could get worseExperts told Newsweek cases will likely soon climb, and that the country is in for a rocky few months\n. First wave still raging No sign of 2020 getting any better, but it could get worse What constitutes a seconds wave when the first wave is stronger than ever?

'Not a sustainable model': A peek at how one high school handles its COVID-19 challengesA peek inside a Sarasota, Florida, high school gives an idea of what classroom instruction looks like with COVID-19. Lots of masks. Students simultaneously on a Zoom call and in class seated behind tri-fold divider shields. watch this if you think you are not happy about your real life OnPurpose Trump is here to KillAmerica COVID19 StephenMiller GOPCorruptionOverCountry

Column: One family’s COVID-19 nightmare shows the pandemic's unjust burden on Latinos in CaliforniaIf you’re Latino in California, even if you have the luxury of a white-collar job, it’s almost a certainty that COVID-19 will stalk the life of someone you love. Covid is racist. watch this if you think you are not happy about your real life Dear American People, Kamala Harris are raising money for supporting crime sabotage past time who has been catched by police was to be released on bail. Minister Ministry of Justice should consider to check, if it's exactly please prosecute Kamala for infringe the law